Find a Tender
complete
Official procurement procedure
Contract for the Genetic Testing of Familial Hypercholesterolaemia (FH)
Pathology services
Published value
Not published
Submission deadline Not published
Lots published1
Procurement Executive Summary
AI & Search Synopsis
Generated from official OCDS record
Tenderline Synopsis: The Newcastle Upon Tyne Hospitals NHS Foundation Trust: "Contract for the Genetic Testing of Familial Hypercholesterolaemia (FH)". Published status: complete. Published value: Value not published. 1 published lot. Submission deadline not published. See the official notice for participation instructions.
| Contracting Authority | The Newcastle Upon Tyne Hospitals NHS Foundation Trust | Scope & Categories | Not published | Submission Window | complete No deadline published |
|---|---|---|---|---|---|
| Submission Gateway | Direct notice route | Legal Basis & Regime | Standard procurement | Estimated Value (exc. VAT) | Not published |
Bidder Intelligence · Authority Profile: The Newcastle Upon Tyne Hospitals NHS Foundation Trust
Market Analytics
Derived from OCDS awards & bid statistics
Published history for The Newcastle Upon Tyne Hospitals NHS Foundation Trust. These figures describe retained records, not a forecast of bids or a measure of buyer bias.
Published-to-award variance
Not availableInsufficient comparable data
Competition Density
2.3Bids / Report
Supplier ConcentrationNo estimate
Insufficient attributable awardsNo concentration estimate availablePayment Terms
Check noticePublished terms
Coverage: 29 active published awards; 24 bid reports (which may be per lot). Supplier values exclude multi-supplier awards, frameworks and DPS, and use GBP only. They are published award values, not payments. Published-to-award variance compares single-lot, single-award, single-supplier GBP procedures with explicitly non-framework/non-DPS status; increases remain in the average. Unpublished data stays unknown. Awarded suppliers are winners, not all bidders.
Procedure terms
Contracting AuthorityThe Newcastle Upon Tyne Hospitals NHS Foundation Trust | Procedure methodNot published | Procurement categoryNot published |
Statuscomplete | Framework / DPSNot published | CompetitionNot published |
Above thresholdNot published | Legal basisNot published | Tender period startsNot published |
Clarification deadlineNot published | Electronic submissionNot published | Submission languagesNot published |
Published5 Dec 2024, 09:03 GMT | Last source update5 Dec 2024, 09:03 GMT | Recurring procurementNot published |
ClassificationPathology services | ||
Delivery area | ||
OCIDocds-h6vhtk-04c262 | ||
What is being bought
To provide Genetic testing for Familial Hypercholesterolaemia (FH) from provided sample taken by Trust
What changed
From the official release history
- Status changed to complete
5 Dec 2024, 09:03 GMT - Official notice release published
5 Dec 2024, 09:03 GMT - Buyer information updated
5 Dec 2024, 09:03 GMT
Lots and requirements (1)
Published by the contracting authority
- Lot 1 · #1Individual lot title not publishedcancelledPublished valueNot publishedTo provide Genetic testing for Familial Hypercholesterolaemia (FH)Contract periodNot publishedEligibilityNot publishedOptions / renewalNot published
Timeline
- Procedure published
5 Dec 2024, 09:03 GMT - Award active
Not published · Not published - Contract active
Signed 4 Jun 2024, 00:00 BST · £405,000
Commercial outcome and competition
Awards Genincode PLC Not published · Not published · active |
Contracts Contract £405,000 · signed 4 Jun 2024, 00:00 BST · active |
Bid statistics bids: 1 (lot 1) |
Buyer and organisations in this procedure
The Newcastle Upon Tyne Hospitals NHS Foundation Trust
Contracting authority GB-FTS-79645Documents (0)
Official links; attachments are not copied
No linked documents are published
Related procedures (0)
No related procedures published
Planning and rationale
Planning budgetNot published |
No-engagement rationaleNot published |
Procedure rationaleGenincode PLC are the only available economic provider who have capacity to facilitate the specialist testing of Familial Hypercholesterolaemia (FH) including reporting to meet the requirements of the national test directory for rare and inherited disorders, NHS England, National genomic test directory including poly genic risk scores. |